SCHEMBL5464073

SCHEMBL5464073

Cc1cccc(S(=O)(=O)Nc2nccc(-c3cc(OC(F)F)ccc3OC(F)F)n2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 3/20 0.41
SLC40A1 Q9NP59 1/20 0.41
NPSR1 Q6W5P4 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
CDK9 P50750 6/20 0.39
CCNT1 O60563 5/20 0.39
PIK3CA P42336 1/20 0.39
MTOR P42345 1/20 0.39
SYK P43405 2/20 0.38
AURKA O14965 1/20 0.38
MAP4K4 O95819 1/20 0.38
ABL1 P00519 1/20 0.38
LCK P06239 1/20 0.38
MET P08581 1/20 0.38
PDGFRB P09619 1/20 0.38
FGFR1 P11362 1/20 0.38
FLT1 P17948 1/20 0.38
KDR P35968 1/20 0.38
FLT3 P36888 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5465550 0.91 SYK (0.41) SCN9ANPSR1CDK9CCNT1PIK3CA
SCHEMBL5472495 0.89 AKT1 (0.44) SCN9ANPSR1MEN1KMT2ACDK9
SCHEMBL5465058 0.89 NPSR1 (0.46) SCN9ANPSR1CDK9CCNT1PIK3CA
SCHEMBL5464963 0.85 PDE4A (0.42) SCN9AMEN1KMT2ACDK9CCNT1
SCHEMBL5460097 0.83 SCN9A (0.40) SCN9ACDK9CCNT1PIK3CAMTOR
SCHEMBL5465468 0.83 MKNK2 (0.38) SCN9ACDK9CCNT1SYKAURKA
SCHEMBL5463011 0.80 ERN1 (0.41) CDK9CCNT1SYK
SCHEMBL5465912 0.79 NPSR1 (0.49) SCN9ANPSR1CDK9CCNT1PIK3CA
SCHEMBL5473201 0.74 CDK9 (0.52) SCN9ASLC40A1NPSR1MEN1KMT2A
SCHEMBL5462677 0.73 AKT1 (0.39) MEN1KMT2APIK3CAMTORPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070099938-A1 Antistress drug and medical use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-05-03 US claimed
EP-1679309-A1 ANTISTRESS DRUG AND MEDICAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP claimed
US-20070099938-A1 Antistress drug and medical use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-05-03 US disclosed
EP-1679309-A1 ANTISTRESS DRUG AND MEDICAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099938-A1 Antistress drug and medical use thereof NPSR1, MC2R, SRR SCN9A 1656/4885SLC40A1 2998/4885NPSR1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.